CXXC5 and hepatocellular carcinoma: Moreover, evidence indicates that CXXC5 can facilitate the TGF-β signaling pathway in hepatocellular carcinoma (HCC) by interacting with HDAC1, and its overexpression was discovered to result in apoptosis and cell cycle arrest in HCC [5].